Table 5 Survival of HIV-TB co-infected divided into different risk categories
From: Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998–2015
All | Died | Alive | Hazard ratio (95% CI) | P-value | |
|---|---|---|---|---|---|
n | n | n | |||
Total | 53 | 16 | 37 | ||
Sex | 0.031 | ||||
Male | 36 | 15 | 21 | 1 | |
Female | 17 | 1 | 16 | 0.15 (0.019–1.10) | |
Mode of HIV-transmission | 0.58 | ||||
IDU | 13 | 7 | 6 | 1.71 (0.53–5.52) | |
MSM | 9 | 4 | 5 | 1.85 (0.49–7.02) | |
Heterosex | 29 | 5 | 24 | 1 | |
Country of birth | 0.14 | ||||
Finland | 26 | 14 | 12 | 4.65 (0.61–35.5) | |
Sub-Saharan Africa | 11 | 1 | 10 | 1 | |
Other | 15 | 1 | 14 | 1.3 (0.081–21.5) | |
Time of TB diagnosis | 0.066 | ||||
> 6 months after HIV diagnosis | 32 | 13 | 19 | 3.07 (0.87–10.8) | |
< 6 months from HIV diagnosis | 29 | 3 | 26 | 1 | |
MDR TB | 2 | 0 | 2 | ||
MAC co-infection | 5 | 1 | 4 | ||
TB recurrence | 1 | 0 | 1 | ||
Age at TB diagnosis, years, mean (range) | 38.9 (20–61) | 42.9 (26–61) | 37.2 (20–56) | 1.06 (1.00–1.13) | 0.036 |
CD4 at TB diagnosis, mean (range) | 203 (5–859) | 258 (5–854) | 181 (9–859) | 1.00 (0.99–1.00) | 0.27 |
CD4 nadir, mean (range) | 131 (1–471) | 118 (1–471) | 137 (9–458) | 1.00 (0.99–1.00) | 0.90 |